Given the California state-wide lockdown, we at Scintillon Institute hope you remain calm and aware while doing your best to follow the governor’s directive for blunting the projected jump in infected cases that could potentially overwhelm our medical system. 

We are doing what we can at Scintillon to provide long term help with all issues related to human health and longevity, viral outbreaks included. We plan on conducting the production of cell and possibly vesicle mediated vaccines against SARS-CoV-2.  We also are working on tissue and organ regeneration to help those who have survived a coronavirus infection and developing nanoantibodies that might be used to treat the cytokine storm/septic shock from which some severe-case patients suffer. 

In the meantime, the biomedical research community will continue to work on all diseases to provide cure and comfort. We are happy to report that just today, one of our faculty members, Dr. Jiwu Wang, and his group published a paper in a Nature family journal about how doctors could treat thyroid cancer with more informed choices. 

https://www.todayinnewyork.com/2020/03/20/scintillon-researchers-publish-new-methods-for-thyroid-cancer-prognosis/

Please stay safe and well.  Your continued support of biomedical research is vital because together, we can handle future outbreaks and other health problems better.

Thank you!

Scintillon Institute

Scintillon Institute proudly hosts

Michael Karin, Ph.D.

 Distinguished Professor of Pharmacology, Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases, American Cancer Society Research Professor (UCSD)

“Positive and Negative Regulation of the NLRP3 Inflammasome Implications on Cancer, Aging and Neurodegeneration”

on October 24^th

at 1pm

Scintillon seminar room at 6868 Nancy Ridge Drive

Scintillon Institute proudly hosts

 Alan S. Verkman, M.D. Ph.D.

 Director of the Cystic Fibrosis Research Development Program at University of California, San Francisco, former Established Investigator for the American Heart Association, and Senior Staff Member of the Cardiovascular Research Institute at University of California, San Francisco

“Cystic fibrosis drug discovery and assay methods”

Scintillon Institute proudly invites you to attend today's Friday lunchtime seminar.

Dr. Erkki Ruoslahti, former President of Sanford-Burnham-Prebys Institute (1989 to 2002) and member of US Academy of Sciences

will present "In vivo phage display in targeting disease" 

today at noon

Scintillon seminar room at 6868 Nancy Ridge Drive